Synthesis and Feasibility Evaluation of a new Trastuzumab Conjugate Integrated with Paclitaxel and 89Zr for Theranostic Application Against HER2-Expressing Breast Cancers.
ChemistryOpen
; 8(4): 451-456, 2019 Apr.
Article
in En
| MEDLINE
| ID: mdl-31008009
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
ChemistryOpen
Year:
2019
Document type:
Article
Country of publication:
Germany